Millions of gastrointestinal endoscopy are performed each year in the US, with colonoscopies making up the majority of such procedures. Research conducted by Michael W. Jopling, MD and Qiu Jiejing published in BMC Anesthesiology concluded that capnography use associated with reduction of adverse outcomes during procedural sedation.
Their research sought to “estimate the incidence of pharmacological rescue events and death at discharge from an inpatient or outpatient hospitalization where [gastrointestinal endoscopic procedures] GEP was performed with sedation, and to determine if capnography monitoring was associated with reduced incidence of these adverse outcomes.”
Millions of colonoscopies and other gastrointestinal endoscopic procedures in the US each year. In 2009, more than 55 million gastrointestinal endoscopic procedures were performed.
Endoscopy is usually a safe procedure and the risk of serious complications is very low. In looking at colonoscopies, which constitute about half of gastrointestinal endoscopic procedures, overall serious adverse event rate was 2.8 per 1000 procedures and the death rate was just 0.03 percent, according to guidelines published by the American Society for Gastrointestinal Endoscopy.
However, the risk of complication rises with the use of sedation. The goal of sedation when used in colonoscopies and other gastrointestinal endoscopic procedures is safely and effectively manage any pain, discomfort, or anxiety the patient may have during the procedure. Read More
The Physician-Patient Alliance for Health & Safety announced today that Michael W. Jopling, MD – currently an Anesthesiologist with NorthStar Anesthesia at several central Ohio medical institutions, Chief Medical Officer of Cardiox Corporation (Columbus), Executive Vice President of Accel Anesthesia (Columbus), and Co-Founder of Medical Electronic Innovations (Milwaukee)– has joined the Physician-Patient Alliance Board of Advisors.